Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(1)
| Drug | Company |
|---|---|
| t-dxd | ASTRAZENECA PLC (AZN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Locally Advanced or Metastatic Non-Small Cell Lung Cancer?
BioSniper tracks 3 drugs in development for Locally Advanced or Metastatic Non-Small Cell Lung Cancer across 3 companies.
How many clinical trials target Locally Advanced or Metastatic Non-Small Cell Lung Cancer?
There are 2 clinical trials targeting Locally Advanced or Metastatic Non-Small Cell Lung Cancer tracked by BioSniper.
Deep-dive into Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis